Edition:
United States

vTv Therapeutics Inc (VTVT.OQ)

VTVT.OQ on NASDAQ Stock Exchange Global Market

3.28USD
12 Oct 2018
Change (% chg)

-- (--)
Prev Close
$3.28
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
350,215
52-wk High
$8.37
52-wk Low
$0.65

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 2.47 -0.306
Mar '18 2.06 -0.304
FY 2017 Dec '17 0.23 0.158
Sep '17 0.01 -0.377
Jun '17 0.01 -0.409
Mar '17 0.03 -0.435
FY 2016 Dec '16 0.04 -0.418
Sep '16 0.04 -0.412
Jun '16 0.18 -0.466
Mar '16 0.38 -0.417
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 1 2.06 2.06 2.06 0.00
Year Ending Dec-18 1 8.66 8.66 8.66 10.05
Year Ending Dec-19 1 5.00 5.00 5.00 43.25
Earnings (per share)
Quarter Ending Dec-18 1 -0.15 -0.15 -0.15 -0.47
Year Ending Dec-18 1 -0.85 -0.85 -0.85 -2.25
Year Ending Dec-19 1 -0.67 -0.67 -0.67 -1.66
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 119.85 32.14
P/E High - Last 5 Yrs. -- 284.29 46.82
P/E Low - Last 5 Yrs. -- 95.75 24.71
Beta -- 0.63 0.87
Price to Sales (TTM) 21.80 109.82 6.55
Price to Book (MRQ) -- 13.72 4.00
Price to Tangible Book (MRQ) -- 20.21 6.10
Price to Cash Flow (TTM) -- 69.50 21.51
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.68
Dividend Yield - 5 Year Avg -- 0.20 1.45
Dividend 5 Year Growth Rate -- 2.61 -5.91
Payout Ratio(TTM) -- 5.68 46.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 18,923.08 157.56 7.91
Sales (TTM) vs TTM 1 Yr. Ago 3,921.01 91.25 6.56
Sales - 5 Yr. Growth Rate -- 25.47 7.49
EPS (MRQ) vs Qtr. 1 Yr. Ago 25.23 297.15 26.63
EPS (TTM) vs TTM 1 Yr. Ago 50.53 -- --
EPS - 5 Yr. Growth Rate -- 25.12 7.65
Capital Spending - 5 Yr. Growth Rate -- 39.11 8.16

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.22
Current Ratio (MRQ) 0.19 5.52 2.99
LT Debt to Equity (MRQ) -- 15.33 11.31
Total Debt to Equity (MRQ) -- 18.80 14.15
Interest Coverage (TTM) -31.60 -216.32 34.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 32.64 54.36
Gross Margin - 5 Yr. Avg. -- 52.76 53.16
EBITD Margin (TTM) -880.48 -- --
EBITD - 5 Yr. Avg -- -164.07 16.13
Operating Margin (TTM) -884.12 -618.88 3.36
Operating Margin - 5 Yr. Avg. -- -178.92 11.28
Pre-Tax Margin (TTM) -950.95 -615.68 3.79
Pre-Tax Margin - 5 Yr. Avg. -- -181.48 11.54
Net Profit Margin (TTM) -849.66 -604.79 0.60
Net Profit Margin - 5 Yr. Avg. -- -179.91 7.83
Effective Tax Rate (TTM) -- 11.98 20.73
Effective Tax Rate - 5 Yr. Avg. -- 19.65 24.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 85,446 24,741,437 725,680,242
Net Income/Employee (TTM) -726,000 1,102,410 84,001,075
Receivable Turnover (TTM) -- 4.18 5.06
Inventory Turnover (TTM) -- 2.14 3.65
Asset Turnover (TTM) 0.20 0.39 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -172.99 0.35 9.83
Return on Assets - 5 Yr. Avg. -- 3.11 10.94
Return on Investment (TTM) -1,907.39 1.96 12.83
Return on Investment - 5 Yr. Avg. -- 2.91 14.05
Return on Equity (TTM) -- 1.12 14.95
Return on Equity - 5 Yr. Avg. -- -0.97 15.39
  1 Year 3 Year 5 Year
Sales % -54.10 -42.73 --
EPS (TTM) % 37.99 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for vTv Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 9.48%
# of Holders: 39
Total Shares Held: 1,084,511
3 Mo. Net Change: -13,064
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 2
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.